Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma

被引:3
|
作者
Mäkitie, T [1 ]
Summanen, P [1 ]
Tarkkanen, A [1 ]
Kivelä, T [1 ]
机构
[1] Univ Helsinki, Cent Hosp, Dept Ophthalmol, Ophthalm Pathol Lab, FIN-00029 Helsinki, Finland
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. Although malignant uveal melanoma disseminates predominantly hematogenously be cause of the absence of intraocular lymphatics, consensus about prognostic impact of microvascular density (MVD) has not been reached. This study was undertaken to investigate whether MVD, microvascular patterns, or both determine prognosis of uveal melanoma. METHODS. A population-based retrospective cohort study of melanoma-specific and all-cause mortality of 167 consecutive patients who had an eye enucleated because of choroidal or ciliary body melanoma from 1972 through 1981 was conducted. MVD was determined by counting tumor vessels in a masked fashion from areas of highest vessel density after immunostaining for CD34 epitope, factor VIII-related antigen (FVIII-RAg), and cu-smooth muscle actin (SMA). Kaplan-Meier and Cox regression analyses of survival were performed. The association between MVD and tumor size and location, cell type, and microvascular patterns was assessed. RESULTS. MVD could be determined from 134 of 167 melanomas (80%). Based on globally highest count obtained with antibodies to CD34, MVD ranged from 5 to 121 vessels/0.313 mm(2) (median, 40) and its association with presence of microvascular loops and networks (P = 0.0006), epithelioid cells (P = 0.028), and largest basal tumor diameter(P = 0.0029) was statistically significant. The 10-year melanoma-specific mortality increased with MVD (0.09, 0.29, 0.59, and 0.64, according to quartiles; P < 0.0001), as did all-cause mortality (P = 0.0022). Equivalent results were obtained with immunostaining for FVIII-RAg- whereas MVD obtained with antibodies to SMA was not associated with prognosis. Cox regression showed a hazard ratio of 2.45 (95% CI, 1.43-4.18) for presence of epithelioid cells, 1.11 (95% CI, 103-1.20) for largest basal diameter, 1.23 (95% CI, 1.06-1.43) for square root-transformed MVD. and 151 (95% CI, 1.09-2.10) for presence of loops and networks, all of which independently contributed to prognosis. CONCLUSIONS. The findings support the theory that both MVD and microvascular patterns contribute independently to prognosis in uveal melanoma in:addition to cell type and size of the tumor.
引用
收藏
页码:2471 / 2480
页数:10
相关论文
共 50 条
  • [11] Survival analysis of stereotactic radiosurgery compared to enucleation for the treatment of choroidal and ciliary body malignant melanoma.
    Cohen, VM
    Carter, MJ
    Rennie, IG
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S219 - S219
  • [12] Iris Melanoma Expresses Higher Levels of PEDF Than Ciliary Body and Choroidal Melanoma
    Zhang, Q.
    Gao, W.
    Yang, H.
    Grossniklaus, H. E.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [13] Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension
    Gündüz, K
    Shields, CL
    Shields, JA
    Cater, J
    Brady, L
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2000, 130 (01) : 97 - 102
  • [14] SURVIVAL RATE OF PATIENTS WITH CHOROIDAL MELANOMA
    LOMMATZSCH, P
    DIETRICH, B
    [J]. OPHTHALMOLOGICA, 1976, 173 (06) : 453 - 462
  • [15] Long-term survival in choroidal and ciliary body melanoma after enucleation versus plaque radiation therapy
    Augsburger, JJ
    Corrêa, ZM
    Freire, J
    Brady, LW
    [J]. OPHTHALMOLOGY, 1998, 105 (09) : 1670 - 1678
  • [16] Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas
    Isager, P
    Ehlers, N
    Overgaard, J
    [J]. ACTA OPHTHALMOLOGICA SCANDINAVICA, 2004, 82 (05): : 517 - 525
  • [17] Tadalafil-induced subretinal and choroidal hemorrhage in a patient with an unsuspected uveal (choroidal and ciliary body) melanoma
    Abramson, David H.
    Rollins, Indira S.
    Lin, Amy
    Odell, Peter
    Folberg, Robert
    [J]. ARCHIVES OF OPHTHALMOLOGY, 2006, 124 (07) : 1058 - 1060
  • [18] The Prognostic Effect of American Joint Committee on Cancer Staging and Genetic Status in Patients With Choroidal and Ciliary Body Melanoma
    Bagger, Mette
    Andersen, Morten T.
    Andersen, Klaus K.
    Heegaard, Steffen
    Andersen, Mette K.
    Kiilgaard, Jens F.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (01) : 438 - 444
  • [19] Survival after enucleation and radiation brachy therapy for choroidal and ciliary body melanomas
    Isager, P
    Ehlers, N
    Overgaard, J
    [J]. ACTA OPHTHALMOLOGICA SCANDINAVICA, 2005, 83 (03): : 398 - 399
  • [20] The Pediatric Choroidal and Ciliary Body Melanoma Study A Survey by the European Ophthalmic Oncology Group
    Al-Jamal, Rana'a T.
    Cassoux, Nathalie
    Desjardins, Laurence
    Damato, Bertil
    Konstantinidis, Lazaros
    Coupland, Sarah E.
    Heimann, Heinrich
    Petrovic, Aleksandra
    Zografos, Leonidas
    Schalenbourg, Ann
    Velazquez-Martin, Juan P.
    Krema, Hatem
    Bogdali, Anna
    Markiewicz, Anna
    Romanowska-Dixon, Bozena
    Metz, Claudia H. D.
    Biewald, Eva
    Bornfeld, Norbert
    Kiratli, Hayyam
    Bronkhorst, Inge H. G.
    Jager, Martine J.
    Marinkovic, Marina
    Fili, Maria
    Seregard, Stefan
    Frenkel, Shahar
    Pe'er, Jacob
    Salvi, Sachin M.
    Rennie, Ian G.
    Rospond-Kubiak, Iwona
    Kociecki, Jaroslaw
    Kiilgaard, Jens Folke
    Heegaard, Steffen
    Cohen, Victoria M. L.
    Sagoo, Mandeep S.
    Amiryan, Anush
    Saakyan, Svetlana
    Md, Nils ide
    Krohn, Jorgen
    Midena, Edoardo
    Parrozzani, Raffaele
    Grange, Jean-Daniel
    Kilic, Emine
    Blasi, Maria Antonietta
    Saornil, Maria Antonia
    Kivela, Tero T.
    [J]. OPHTHALMOLOGY, 2016, 123 (04) : 898 - 907